Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection

Clinical trial NCT04218513 · COMPLETED

Trial details

NCT number: NCT04218513
Sponsor: Nanjing Yoko Biomedical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug-drug Interaction

Start date: 2019-05-10
Primary completion: 2019-05-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.